Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Chronic lymphocytic leukemia (CLL): first-line treatment Hallek MHematology Am Soc Hematol Educ Program 2005[]; ä (ä): 285-91For the past ten years, there has been a dynamic development of new therapeutic compounds and prognostic parameters for chronic lymphocytic leukemia (CLL). Hematologists and oncologists are challenged to use these new possibilities for an optimized, risk- and fitness-adapted treatment strategy, with the goal of achieving long-term remissions and preserving a good quality of life. This review is intended to summarize the current knowledge on first-line treatment of CLL.|Anemia/epidemiology[MESH]|Antibodies, Monoclonal, Murine-Derived[MESH]|Antibodies, Monoclonal/therapeutic use[MESH]|Antineoplastic Agents/therapeutic use[MESH]|Antineoplastic Combined Chemotherapy Protocols/therapeutic use[MESH]|Chromosome Aberrations[MESH]|Chromosome Deletion[MESH]|Chromosomes, Human, Pair 11[MESH]|Chromosomes, Human, Pair 13[MESH]|Chromosomes, Human, Pair 17[MESH]|Humans[MESH]|Immunotherapy/methods[MESH]|Leukemia, Lymphocytic, Chronic, B-Cell/*drug therapy/genetics/pathology[MESH]|Neoplasm Staging[MESH]|Prognosis[MESH]|Quality of Life[MESH]|Rituximab[MESH]|Thrombocytopenia/epidemiology[MESH] |